Literature DB >> 28866642

The quantitative link of lung clearance index to bronchial segments affected by bronchiectasis.

Sylvia Verbanck1, Gregory G King2, Wenxiao Zhou3, Anne Miller3, Cindy Thamrin2, Daniel Schuermans1, Bart Ilsen4, Caroline W Ernst4, Johan de Mey4, Walter Vincken1, Eef Vanderhelst1.   

Abstract

In adult patients with cystic fibrosis (CF), the lung clearance index (LCI) derived from the multiple breath washout relates to both acinar and conductive ventilation heterogeneity. The latter component predicts an association between LCI and the number of bronchial segments affected by bronchiectasis. Here, we experimentally demonstrated this association in patients with CF, and also examined an ancillary group of patients with non-CF bronchiectasis. We conclude that lung disease severity in terms of number of bronchial segments results in an associated LCI increase, likely constituting a portion of LCI that cannot be reversed by treatment in patients with CF lung disease. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  Bronchiectasis; Cystic Fibrosis; Exhaled Airway Markers; Imaging/CT MRI; Respiratory Measurement

Mesh:

Year:  2017        PMID: 28866642     DOI: 10.1136/thoraxjnl-2017-210496

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  2 in total

1.  Multiple-Breath Washout Outcome Measures in Adults with Bronchiectasis.

Authors:  Katherine O'Neill; Gokul R Lakshmipathy; Curtis Neely; Denise Cosgrove; Kathryn Ferguson; Rebecca McLeese; Adam T Hill; Michael R Loebinger; Mary Carroll; James D Chalmers; Timothy Gatheral; Chris Johnson; Anthony De Soyza; John R Hurst; Ian Bradbury; Joseph S Elborn; Judy M Bradley
Journal:  Ann Am Thorac Soc       Date:  2022-09

2.  Quantitative Computed Tomography in Asthma: For Good Measure.

Authors:  Sylvia Verbanck
Journal:  Am J Respir Crit Care Med       Date:  2020-04-15       Impact factor: 21.405

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.